AtheroNova ($AHRO) C.E.O. Thomas W. Gardner on atherosclerosis market size (video)

Wednesday, April 18, 2012 at 11:48AM
Michael W Sweeney in Specialty Pharma, ahro, film annex

AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits.

In this film, AtheroNova C.E.O. Thomas W. Gardner speaks about the market size for atherosclerosis:

Watch more on Film Annex

Article originally appeared on Daily Dose Equities - Wall Street Analysis for Biomedical Research (http://dailydoseequities.filmannex.com/).